HealthStream, Inc. (HSTM) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals positive financial performance with growth in key products, increased net income, and improved cash balance. The transition to higher-margin SaaS and PaaS applications supports future margin growth. Despite a decline in gross margin, optimistic guidance and strategic moves, like AI integration and new product launches, indicate potential upside. The Q&A section highlights opportunities in monetization and market expansion, although some areas lack detailed projections. Overall, the sentiment leans positive due to strong financials and strategic initiatives, suggesting a potential stock price increase of 2% to 8%.
Key Financial Performance
Quarterly Revenue $76.5 million, up 4.6% year-over-year. The increase was driven by strong performance in subscription products, particularly CredentialStream (up 23%), ShiftWizard (up 29%), and Competency Suite (up 18%). However, professional service revenues declined by 18.6%.
Operating Income $7.6 million, up 16.5% year-over-year. The increase was attributed to higher subscription revenue and cost management.
Net Income $6.1 million, up 6.3% year-over-year. The growth was supported by increased revenues and cost efficiencies.
Adjusted EBITDA $19.1 million, up 7.9% year-over-year. The improvement was due to higher subscription revenue and operational efficiencies.
Gross Margin 65.3%, down from 66.5% in the prior year. The decline was due to increased cloud hosting and software licensing costs, primarily for CredentialStream and the hStream platform.
Cash Balance $92.6 million at the end of the third quarter, up from $90.6 million in the previous quarter. The increase was driven by strong cash flows from operations.
Free Cash Flow $24.7 million year-to-date, down from $25.2 million last year. The decline was primarily due to a $4.1 million increase in capital expenditures.
Days Sales Outstanding (DSO) 33 days, improved from 37 days last year. The improvement was due to more timely customer payments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Virsys12 Acquisition: HealthStream acquired Virsys12, a healthcare technology company, to strengthen its entry into the payer and health plan space. This acquisition adds a provider data management suite and expands expertise in the payer market.
Career Networks: HealthStream introduced 'career networks' targeting healthcare professionals and students. Examples include myClinicalExchange and NurseGrid, which help users manage their careers and connect with opportunities.
CredentialStream: CredentialStream application revenues grew by 23% in Q3 2025, driven by its ability to reduce physician onboarding time.
ShiftWizard: ShiftWizard, a scheduling application, saw a 29% revenue growth in Q3 2025, surpassing legacy products.
Payer Market Expansion: The acquisition of Virsys12 positions HealthStream to expand its footprint in the payer and health plan market, with over 25 active accounts.
Career Networks Expansion: The career networks initiative targets 12.6 million healthcare professionals and students in the U.S., aiming to connect them with enterprise solutions.
Revenue Growth: Record quarterly revenues of $76.5 million, up 4.6% year-over-year.
Subscription Revenue: Subscription revenues grew by 5.7%, driven by CredentialStream, ShiftWizard, and Competency Suite.
Cash Position: Strong cash balance of $92.6 million with no debt.
Focus on SaaS and PaaS: HealthStream is focusing on SaaS and PaaS solutions to integrate career networks with enterprise applications.
Customer Retention and Expansion: High customer retention with 96% subscription-based revenue and cross-selling opportunities like Competency Suite bundles.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Cloud hosting and software licensing costs: Gross margin was impacted by an increase in cloud hosting costs and software licensing costs, primarily for the CredentialStream application and the hStream platform.
Decline in legacy products: Revenues from legacy credentialing and scheduling applications declined by $1.7 million compared to last year, and a $3 million expected decline in legacy products is anticipated for the full year.
Gross margin pressure: Gross margin decreased to 65.3% from 66.5% in the prior year quarter, indicating cost pressures.
Capital expenditures: Capital expenditures increased by $4.1 million year-to-date, impacting free cash flows.
Professional service revenues: Professional service revenues were down $0.6 million or 18.6% compared to last year.
Integration and acquisition risks: The acquisition of Virsys12 involves integration challenges and financial risks, including contingent payments of up to $4 million based on financial targets.
Customer payment timelines: Although days sales outstanding improved, timely customer payments remain a critical factor for cash flow stability.
Market competition: Competitive pressures in the credentialing and scheduling markets require continuous innovation to maintain market share.
Economic uncertainties: Economic conditions could impact customer budgets and spending on HealthStream's solutions.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Full Year 2025 Financial Guidance: HealthStream updated its financial guidance for the full year 2025, maintaining the same midpoints as previous guidance but narrowing the range for each financial metric. Consolidated revenues are expected to range between $299.5 million and $301.5 million. Net income is projected to range between $20.3 million and $21.5 million. Adjusted EBITDA is expected to range between $69.5 million and $71.5 million. Capital expenditures are projected to range between $33 million and $34 million. This guidance includes contributions of approximately $900,000 from the recent Virsys12 acquisition but excludes assumptions for any additional acquisitions during the remainder of the year.
Revenue Growth Expectations: Revenues from subscription products are expected to continue growing, supported by strong performance from core solutions such as CredentialStream, ShiftWizard, and the Competency Suite. CredentialStream revenues grew by 23%, ShiftWizard by 29%, and the Competency Suite by 18% in the third quarter of 2025 compared to the same period last year. The company expects approximately 39% of its remaining performance obligations to convert to revenue over the next 12 months and 67% over the next 24 months.
Market Expansion and Product Integration: The acquisition of Virsys12 is expected to strengthen HealthStream's entry into the payer and health plan market, expanding its customer footprint and expertise in this area. The integration of Virsys12 with HealthStream's Network product is anticipated to enhance the company's offerings in provider data management, onboarding, credentialing, and network management. Additionally, the company is focusing on connecting its career networks with enterprise application suites through its hStream platform, which is expected to drive future growth and innovation.
Operational Efficiency and Innovation: HealthStream is enhancing its CredentialStream application to reduce the time it takes for physicians to onboard, enroll, credential, and privilege, aiming to shorten the current 120-day process. This initiative is expected to improve productivity and profitability for customers while benefiting patients by expediting physician availability.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly cash dividend: The Board of Directors declared a quarterly cash dividend of $0.031 per share, to be paid on November 28 to holders of record as of November 17.
Share repurchase program: The company repurchased $6.9 million of common stock during the third quarter, completing the $25 million share repurchase program authorized in May.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the key differences in the payer market, and what opportunities do you see there over the next few years?
A:The payer market uses a mix of technologies, including the adapted CredentialStream application. The acquisition of Virsys12 adds expertise and technology to better meet customer needs. There are synergies between payers and providers, particularly in transferring core primary source verified data sets. Tammy Hawes, CEO of Virsys12, has joined to lead efforts in this market.
Q:Where do you see EBITDA margin growth going over time, especially with the shift to owning more content?
A:The company has moved from a 55%-65% margin range to higher margins due to a shift to higher-margin SaaS and PaaS applications. New products generally have higher margins, but partner products like the American Red Cross Resuscitation Suite have lower margins. Overall, the trajectory is towards higher margins as the product mix evolves.
Q:Can you provide revenue details for Virsys12, including the mix between recurring and periodic revenue?
A:The expected revenue contribution from Virsys12 in Q4 is approximately $900,000. There is a mix of subscription revenue and consulting revenue, but the exact breakdown was not provided.
Q:How is the monetization of career networks progressing, and what opportunities do they provide for expanding TAM?
A:NurseGrid is growing organically with 2,000 new subscribers weekly. Monetization strategies include direct education sales, job postings, partnerships like Plenary for student debt consolidation, and tools for enterprise customers to communicate with the network. MyClinicalExchange charges a $30 fee for student registration, with costs shared among students, nursing schools, and hospitals. The company is exploring LinkedIn and Doximity-style monetization models.
Q:Do you see opportunities to monetize platforms like Doximity does with brand marketing?
A:Yes, the company is modeling NurseGrid after LinkedIn and Doximity, aiming to become the #1 social network for nurses. They see potential in brand marketing and other monetization strategies, especially given the importance of nurses to health systems.
Q:What was the growth for HLC CredentialStream and ShiftWizard? Was it bookings or revenue contribution?
A:The growth rates of 7% for HLC, 23% for CredentialStream, and 29% for ShiftWizard represent revenue contribution year-over-year growth.
Q:Is ShiftWizard ready to penetrate large organizations, and were there any large sales in the quarter?
A:ShiftWizard is not yet ready for the largest organizations but is making progress with medium to large enterprises. The company has secured $1 million-plus contracts and is working on data management improvements.
Q:What is the update on the small and rural hospital markets?
A:The company is addressing financial pressures in small hospitals with bundling strategies, such as the Critical Access bundle, which combines software and content. This approach simplifies decision-making and offers economical solutions.
Q:Do you have any closing remarks about guidance and legacy software?
A:The guidance remains unchanged with tightened ranges. Legacy software is expected to decline by $3 million in Q4, offsetting growth in new products. The company emphasizes the importance of considering legacy issues when modeling growth.
Q:Review of Unclear Management Responses
A:Management avoided providing a detailed breakdown of the revenue mix between subscription and consulting for Virsys12. Additionally, while they discussed monetization strategies for career networks, they acknowledged that these efforts are in their infancy and did not provide specific financial projections or timelines.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
CEO Chair
CEO Co
CEO revenue
CFO update
Chair HealthStream
Chairman CEO
Co Founder
Communications today
CredentialStream ShiftWizard
Founder Chairman
HealthStream acquisition
HealthStream demand
Network
SaaS enterprise
Virsys acquisition
acquisition Virsys
addition
adjustment
amortization
basis cash
care professional
care technology
care workforce
career network
class solution
consideration
date basis
enterprise class
expertise
health care
legacy credentialing
payer health
payer market
payment
priority
program stock
record
revenue income
space
start
HSTM Transcript
HealthStream, Inc. (HSTM) Q1 2026 Earnings Call Transcript
Positive5-5
The earnings call shows solid financial performance with revenue, operating income, and net income all increasing year-over-year. The positive cash flow and EPS growth further support a favorable outlook. Despite not discussing strategic initiatives or returns, the strong financial metrics and demand for workforce solutions indicate a positive market reaction. The lack of new risks or uncertainties in the Q&A also reinforces this sentiment.
HealthStream, Inc. (HSTM) Q4 2025 Earnings Call Transcript
Positive2-24
The earnings call summary indicates strong subscription revenue growth, particularly in key products like CredentialStream and ShiftWizard, alongside optimistic revenue guidance. Despite some concerns over professional services and legacy revenue, the company's strategic focus on AI and product integration suggests future growth potential. The Q&A section highlighted positive analyst sentiment, despite some evasive management responses. The stock is likely to see a positive movement, potentially boosted by the company's strong financial metrics and optimistic guidance.
HealthStream, Inc. (HSTM) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call reveals positive financial performance with growth in key products, increased net income, and improved cash balance. The transition to higher-margin SaaS and PaaS applications supports future margin growth. Despite a decline in gross margin, optimistic guidance and strategic moves, like AI integration and new product launches, indicate potential upside. The Q&A section highlights opportunities in monetization and market expansion, although some areas lack detailed projections. Overall, the sentiment leans positive due to strong financials and strategic initiatives, suggesting a potential stock price increase of 2% to 8%.
HealthStream, Inc. (HSTM) Q2 2025 Earnings Call Transcript
Unknown8-5
The earnings call shows a mix of positive and negative factors. Strong growth in core products and improved financial metrics are positive, but declines in legacy products and gross margin pressures are concerning. The Q&A section highlights uncertainties in gross margin recovery and pipeline building for new products. Despite revenue growth, the lack of precise guidance on key issues and the impact of healthcare employment cuts add uncertainty. Given these mixed signals, the stock price is likely to remain stable, leading to a neutral prediction.
HSTM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
